COVID testing-related sales for Abbott totaled $69 million in the most recent quarter, down significantly from $265 million in the same period last year. (Abbott) Medical devices continue to be a ...

Abbott stock jumped Wednesday despite a mixed first-quarter report thanks to light sales of its Covid tests. Sales at Abbott Laboratories' (ABT) other segments, though, "were modestly better than the ...

Abbott Laboratories said Wednesday it received federal emergency use authorization for its rapid COVID-19 test to be used at peoples' homes, with results available in 15 minutes. The medical device ...

Abbott has scored yet another Emergency Use Authorization for rapid coronavirus testing – this one, named BinaxNOW COVID-19 Ag Card, come in the form of a card and can provide results in 15 minutes.

Abbott's diabetes segment fared particularly well: CEO Robert Ford touted the FreeStyle Libre continuous glucose monitor’s $5.3 billion in 2023 sales and 24% growth in the fourth quarter alone, adding ...

Abbott Laboratories (Abbott), a world-leading medical devices and healthcare company, is one of the leaders in Covid-19 testing with its three diagnostic PCR tests: the ID NOW, m2000, and Alinity m.

(Reuters) - The U.S. Food and Drug Administration said on Thursday that Abbott Laboratories’ speedy coronavirus test, which can deliver results within minutes and is used at the White House, could ...